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Abstract
Introduction: Bone marrow lesions (BMLs) play an important role in knee osteoarthritis, but their etiology is not
well understood. The aim of this longitudinal study was to describe the association between dietary factors, serum
lipids, and BMLs.
Methods: In total, 394 older men and women (mean age, 63 years; range, 52 to 79) were measured at baseline
and approximately 2.7 years later. BMLs were determined by using T2-weighted fat-saturation magnetic resonance
imaging (MRI) by measuring the maximal area of the lesion. Nutrient intake (total energy, fat, carbohydrate, protein,
and sugar) and serum lipids were assessed at baseline.
Results: Cross-sectionally, dietary factors and lipids were not significantly associated with BMLs. Energy,
carbohydrate, and sugar intake (but not fat) were positively associated with a change in BML size (b = 15.44 to
19.27 mm2 per 1 SD increase; all P < 0.05). High-density lipoprotein (HDL) cholesterol tended to be negatively
associated with BML change (b = -11.66 mm2 per 1 SD increase; P = 0.088).
Conclusions: Energy, carbohydrate, and sugar intake may be risk factors for BML development and progression.
HDL cholesterol seems protective against BMLs. These results suggest that macronutrients and lipids may be
important in BML etiology and that dietary modification may alter BML natural history.
Introduction
Osteoarthritis (OA) is a whole-organ disease character-
ized by gradual loss of articular cartilage. Strong evi-
dence suggests that bone plays an important role in the
pathogenesis of OA, and it has been suggested that
bone changes may precede cartilage damage [1]. Bone
marrow lesions (BMLs), visible by using magnetic reso-
nance imaging (MRI), have been recognized as a clini-
cally important feature in OA [2,3]. A number of
studies have linked BMLs with knee pain [2,4-6]. They
are also associated with many structural changes in the
knee, such as cartilage-defect progression [7,8] and car-
tilage loss [7-10] on MR images, and they predict joint-
replacement surgery [6,11].
Growing evidence implicates nutritional factors in OA
[12]. Specifically, nutrient and dietary supplements have
been shown to be effective in relieving OA symptoms,
and some may play a role in the course of the disease
[13]. Elevated levels of fat and n-6 polyunsaturated fatty
acids have been found in human OA bone [14]; whereas
n-3 polyunsaturated fatty acids have been shown to
modulate catabolic factors in articular cartilage destruc-
tion [15]. Recent studies have begun to examine the
relation between fatty acids and BMLs. Wang et al. [16]
reported that higher intakes of monounsaturated, total,
and n-6 polyunsaturated fatty acids were associated with
BMLs cross-sectionally [16]. In a recent longitudinal
design, they showed that increased saturated fat intake
was associated with incident BMLs [17]. These results
require confirmation in different settings.
Although many attempts have been made to establish
a relation between food and OA [13], to the best of our
knowledge, no study has examined whether dietary
components other than fat intake, such as total energy,
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protein, carbohydrate, and/or sugar intake are associated
with BMLs.
Research has shown that the prevalence of vascular
disease is high among people with OA [14,18]. Evidence
suggests that these diseases may share risk factors, such
as obesity, hypertension, high low-density lipoprotein
(LDL) levels, elevated total cholesterol, diabetes, smok-
ing, and diet [14,18-21]. Vascular pathology may contri-
bute to the development of OA through its effects on
the subchondral bone. Blood flow through the small
vessels in the subchondral bone may be reduced by
venous occlusion, which results in impaired venous cir-
culation underlying the cartilage plate, joint hyperten-
sion, hypercoagulability, and/or microemboli [19]. These
may result in subchondral bone ischemia, which can
contribute to decreased nutrient supply to the overlying
cartilage plate [19]. Subchondral bone ischemia can also
affect osteocyte death, leading to bone resorption, redu-
cing the viability of subchondral bone [19,22]. BML his-
tology is heterogeneous and includes osteonecrosis,
edema, trabecular abnormalities, and bone remodeling
[23]. Additional MRI-histologic correlation studies of
these lesions have demonstrated fat cell destruction and
fibrovascular regeneration in the lesion area [24], as well
bone marrow fibrosis in well-defined subchondral zones
of OA [25]. Hunter et al. [26] demonstrated that BMLs
are sclerotic compared with unaffected regions from the
same individual, based on the increased bone-volume
fraction and increased trabecular thickness. Recently,
Leydet-Quilici et al. [27] showed that BMLs can be
separated into edema-like and necrosis-like on MR
images. Edema-like MR patterns were associated with
histologic edema and, to a lesser extent, vascular fibro-
sis, whereas necrosis-like MR patterns were associated
with histologic necrosis combined with fibrosis [27].
BMLs have also been linked to ischemia and/or reperfu-
sion injury [22,28]. Therefore, it is possible that vascular
pathology may influence BML development. To our
knowledge, only one study examined serum lipids and
BMLs, reporting that serum cholesterol and triglyceride
levels were associated with an increased incidence of
BMLs [29]. However, this study was conducted in
asymptomatic women; therefore, further studies are
needed in different populations to confirm this finding.
Additionally, we do not know whether serum lipids are
associated with BML progression.
The aim of this study, therefore, was to describe the
association between dietary factors, serum lipids, and
BMLs in a population-based sample of older adults.
Materials and methods
Subjects
This study was conducted as part of the Tasmanian
Older Adult Cohort (TASOAC) study, an ongoing
prospective, population-based study aimed at identifying
the environmental, genetic, and biochemical factors
associated with the development and progression of OA
at multiple sites (hand, knee, hip, and spine). Subjects
between the ages of 50 and 80 years were randomly
selected from the electoral roll in Southern Tasmania
(population, 229,000), with an equal number of men
and women. The overall response rate was 57%. As
TASOAC was designed to examine community-dwelling
older adults, institutionalized older adults were
excluded. Participants also were excluded if they
reported contraindications for MRI. Of all initially eligi-
ble participants, 1,100 enrolled in the study, and 1,099
attended a baseline clinic between March 2002 and Sep-
tember 2004. Follow-up data were collected for 875 eli-
gible participants at a subsequent clinic approximately 2
to 3 years later. The MRI machine was decommissioned
halfway through the follow-up period; therefore, MRI
scans were available for only approximately half of the
follow-up participants (n = 425 of 875). The current
study consists of a sample of 394 TASOAC participants
who had MRI measures at baseline and follow-up and
dietary and lipid measures at baseline.
All research conducted was in compliance with the
Declaration of Helsinki and was approved by the South-
ern Tasmanian Health and Medical Human Research
Ethics Committee. All subjects gave informed written
consent.
Baseline anthropometrics and questionnaire
Weight was measured to the nearest 0.1 kg (with shoes,
socks, and bulky clothing removed) by using a single
pair of electronic scales (Seca Delta Model 707). Height
was measured to the nearest 0.1 cm (with shoes and
socks removed) by using a stadiometer. Body mass
index (BMI) was calculated as kilograms per square
meter. Self-report of smoking status, statin use, and dis-
ease status, such as cardiovascular disease and diabetes,
was recorded by questionnaire.
Magnetic resonance imaging
MRI of the right knee was acquired at baseline and fol-
low-up with a 1.5-T whole-body magnetic resonance
unit (Picker, Cleveland, OH, USA) by using a commer-
cial transmit/receive extremity coil. Image sequences
included the following: (a) a T1-weighted fat-saturation
three-dimensional (3D) gradient-recalled acquisition in
the steady state; flip angle, 30 degrees; repetition time,
31 milliseconds; echo time, 6.71 ms; field of view, 16
cm; 60 partitions, 512 × 512-pixel matrix; acquisition
time, 5 minutes 58 seconds; one acquisition; sagittal
images were obtained at a slice thickness of 1.5 mm
without a interslice gap; and (b) a T2-weighted fat-
saturation two-dimensional (2D) fast spin echo, flip
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angle, 90 degrees; repetition time, 3,067 milliseconds;
echo time, 112 milliseconds; field of view, 16 cm, 15
partitions, 228 × 256-pixel matrix; sagittal images were
obtained at a slice thickness of 4 mm with an interslice
gap of 0.5 to 1.0 mm.
Bone marrow lesions
Subchondral BMLs were assessed on T2-weighted MR
images by using Osiris software and defined as areas of
increased signal adjacent to the subcortical bone at the
medial tibial, medial femoral, lateral tibial, and lateral
femoral sites. One trained observer scored the BMLs by
measuring the maximal area of the lesion at baseline
and follow-up, as previously described [6]. The observer
manually selected the MRI slice with the greatest BML
size. The BML with the highest score was used if more
than one lesion was present at the same site. The maxi-
mal area was measured in square millimeters by using
software cursors. Baseline and follow-up MRIs were
read paired with the chronologic order known to the
observer. Intraobserver repeatability of our areal BML
measurement was assessed by randomly selecting 40
subjects with a BML to have their MRI scans re-read
after at least a 2-week interval. The reader was blinded
to the original BML measurements. Each BML present
was remeasured at the medial tibial, medial femoral, lat-
eral tibial, and lateral femoral sites. We compared the
areal measurement 1 with the areal measurement 2 at
each site where a BML was present. The intraclass cor-
relation coefficient (ICC) was 0.97. At baseline and fol-
low-up, participants were given a BML score (in square
millimeters) at the medial tibial, medial femoral, lateral
tibial, and lateral femoral sites. These were summed to
create a total BML score. Figure 1(a and b) illustrates a
change in BML size from baseline to follow-up.
Dietary factors
Baseline dietary information was collected with the use
of a self-administered, 74-item validated food-frequency
questionnaire (FFQ) that was developed specifically for
use in Australian adults [30,31]. Ten possible frequency
responses were available for each food item, ranging
from “never or less than once per month” to “3 or more
times per day.” This information was used to compute
specific nutrient intakes, such as total energy (kJ/day),
fatty acid (total fats, monounsaturated, polyunsaturated,
and saturated (g/day)), carbohydrate (g/day), protein (g/
day), and sugar (g/day).
Information regarding over-the-counter medication
included information about vitamin and mineral supple-
mentation and natural and herbal medications. We have
chosen not to include these as part of nutrient intake in
the current study because supplements have become
more complex, with different brands containing highly
variable ingredient combinations. As a result, evidence
now suggests that brief and simple questionnaires (those
that have been used in the current study) do not accu-
rately reflect supplement intake, and more validated
methods are necessary [32]. Therefore, we limited our
definition of nutrient intake to those data obtained from
the FFQ.
Serum lipids
Blood samples were collected at baseline after a 12-hour
overnight fast, and assays were conducted to measure
enzymatically the total cholesterol, high-density lipopro-
tein (HDL) cholesterol, and triglycerides by using an
Olympus AU5400 automated analyzer. The concentra-
tion of LDL cholesterol was calculated by using the Frie-
dewald formula [33]. Assays were performed on thawed
blood samples.
Radiographic osteoarthritis
A standing anteroposterior semiflexed view of the right
knee with 15 degrees of fixed knee flexion was per-
formed at baseline and scored individually for osteo-
phytes and joint-space narrowing (JSN) on a scale of 0
to 3 (0 = normal, and 3 = severe) according to the Alt-
man atlas [34], as previously described [35]. The pre-
sence of radiographic OA (ROA) was defined as any
score ≥1 for JSN or osteophytes.
Additional available data
Cartilage defects were assessed on T1-weighted MR
images (score range, 0 to 4) at the medial tibial, medial
femoral, lateral tibial, and lateral femoral sites, as pre-
viously described [36], as follows: grade 0 = normal car-
tilage; grade 1 = focal blistering and intracartilaginous
low-signal-intensity area with an intact surface and base;
grade 2 = irregularities on the surface or base and loss
(A) 
(B) 
Figure 1 Examples of bone marrow lesion (BML) change. (a)
BML increase from baseline to follow-up. (b) BML decrease from
baseline to follow-up [6].
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of thickness < 50%; grade 3 = deep ulceration with loss
of thickness > 50%; and grade 4 = full-thickness chon-
dral wear with exposure of subchondral bone. A carti-
lage defect also had to be present on at least two
consecutive slices. The cartilage was considered to be
normal if the band of intermediate signal intensity had a
uniform thickness. The highest score was used if more
than one defect was present on the same site.
Meniscal damage evaluation was performed by a
trained observer, as previously described [37]. In brief,
the proportion of the menisci affected by a tear or a
partial or full extrusion was separately scored (yes/no)
on the medial and lateral edges of the tibiofemoral joint
at the anterior, middle, and posterior horns.
PA was assessed as steps per day, as determined by
pedometer (Omron HJ-003 and HJ-102; Omron Health-
care, Kyoto, Japan), as previously described [35]. In
brief, each participant was told to wear the pedometer
for 7 consecutive days and to record the number of
steps each day and the duration and type of PA for any
activities in which the pedometer could not be worn
(for example, swimming). An average of the 7 days was
used to give each participant a mean steps-per-day
value. Participants were then mailed a second ped-
ometer after a 6-month period and repeated the process.
A steps-per-day value, which was an average of the steps
per day in summer and winter, was calculated.
Data analysis
The t tests and c2 tests were used to compare differ-
ences in means and proportions, as appropriate. Logistic
regression was used to examine the associations between
baseline BMLs (absent versus present) with baseline
dietary factors and lipids after adjustment for age, sex,
BMI, smoking, cardiovascular diseases, diabetes, ROA,
and statin use in the lipids model.
Mixed-effect models were used to examine the asso-
ciation between change in total BML area and baseline
dietary factors and lipids after adjustment for age, sex,
BMI, baseline BMLs, smoking, cardiovascular diseases,
diabetes, ROA, time to follow-up, and statin use in the
lipids model. Standard diagnostic checks of model ade-
quacy and unusual observations were performed and
revealed that change in BML area was not normally dis-
tributed. The data are clumped at zero because a large
proportion of participants did not have a BML at base-
line or follow-up. However, the distribution remains not
normal even after box-cox transformation. As a result,
we have analyzed change in BML area as it was, but
performed two separate analyses examining (a) BML
size change at all four sites (medial tibial, medial
femoral, lateral tibial, and lateral femoral); and (b) total
BML size change (all four sites combined). This was
done to check the consistency of our results.
Logistic regression analysis was used to examine the
association between BMLs that have completely resolved
and dietary factors and lipids after adjustment for age,
sex, BMI, ROA, and statin use in the lipids model.
To compare with a previous study [17], a separate
analysis examined only incident BMLs with baseline
dietary factors and lipids. As we used a continuous,
quantitative measure of BML size, we defined incident
BMLs based on the least-significant criterion (LSC) [38].
We used this equation in a recent article [6] to define
significant changes in BML size when assessing BMLs as
a continuous measure. The LSC takes into account mea-
surement error and the correlation between the BML
measurements at baseline and follow-up. The formula
was as follows:
LSC = 1.96× σ
√
2(1− ρ)
where s is the standard error of the mean, and r is
the serial correlation. LSC was calculated to be 25 mm2
(where s = 11.67 and r = 0.38). Therefore, incident
BMLs were defined as any new BML in those with no
BMLs at baseline larger than 25 mm2. Logistic regres-
sion analysis was performed to examine incident BMLs
with dietary factors and lipids after adjustment for age,
sex, BMI, ROA, and statin use in the lipids model.
Standard diagnostic checks of model adequacy and
unusual observations were performed for all models.
Hosmer-Lemeshow tests were performed to assess
goodness-of-fit for the logistic regression models. The
result for each logistic regression was > 0.05, indicating
that the model fits were adequate. Each dietary factor
was entered into a separate multivariable model to avoid
collinearity. A P value less than 0.05 (two-tailed) was
considered statistically significant. All statistical analyses




In total, 1,099 subjects (51% female) aged between 51
and 81 years (mean, 63 years) participated in the
TASOAC study. The current study consists of a sample
of 394 TASOAC participants who had MRI measures at
baseline and follow-up (approximately 2.7 years) and
dietary and lipid measures at baseline. The range of fol-
low-up times was 2.0 to 4.7 years. The majority of parti-
cipants (90%) were followed up between 2.2 and 3.2
years. No significant differences were found in demo-
graphics, baseline energy intake, fatty acid intake, carbo-
hydrate intake, protein intake, sugar intake, total
cholesterol, triglycerides, LDL cholesterol, HDL choles-
terol, ROA, or statin use between the rest of the cohort
(n = 705) and the subjects included in the current study
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(n = 394). The characteristics of the study population
are presented in Table 1. Those participants with a
BML present at baseline (n = 0.168) were more likely to
be male (P = 0.02) and had a higher BMI (P = 0.01) and
a lower total and HDL cholesterol (P = 0.01). Total
BML area at baseline ranged from 0 to 727 mm2. The
change in total BML area ranged from -710 to 1,344
mm2.
Statin use was not associated with baseline BMLs (OR,
1.22; P = 0.452); however, those taking statin medication
had a significantly lower total cholesterol level (OR,
0.51; P < 0.001), higher triglyceride level (OR, 1.64; P <
0.001), and lower LDL cholesterol level (OR, 0.23; P <
0.001); therefore, we adjusted for statin use in the multi-
variable analysis examining lipids.
Cross-sectional results
Table 2 documents the associations between baseline
BMLs with dietary factors and lipids. Dietary factors and
lipids were not significantly associated with baseline
BMLs in a multivariable model.
BML change
The association between baseline dietary factors and
lipids with change in total BML size is presented in
Table 3. Change in BMLs was significantly positively
associated with energy, carbohydrate, and sugar intake
in a multivariable model, adjusting for age, sex, BMI,
baseline BMLs, smoking, cardiovascular diseases, dia-
betes, ROA, and time to follow-up. No significant asso-
ciations were found between total fat intake or
individual fats (monounsaturated, polyunsaturated, and
saturated fat) and BML change. After adjustment for
age, sex, BMI, baseline BMLs, smoking, cardiovascular
diseases, diabetes, ROA, time to follow-up, and statin
use, HDL cholesterol tended to be negatively associated
with change in BMLs.
Similar results were seen when area change at all four
sites (medial tibial, medial femoral, lateral tibial, and lat-
eral femoral) was used instead of total area change. This
demonstrates consistency in our findings, showing that
energy, carbohydrate, and sugar intake were positively
associated with a BML change; and HDL cholesterol
tended to be negatively associated with BML change.
No differences were found in the relation between
dietary factors and lipids with change in BMLs in those
with and without ROA, as no interaction terms with
ROA were significant.
Resolving BMLs
Twenty-one subjects had complete BML resolution, and
147 subjects did not have complete BML resolution in
those with a baseline BML. In a univariate analysis,
HDL cholesterol was associated with resolving BMLs
(OR, 1.67; P = 0.041), and after adjustment for age, sex,
BMI, ROA, and statin use, this remained significant
(OR, 2.00; P = 0.027). No dietary factors were associated
with BML resolution.
Incident BMLs
The relation between baseline dietary factors and lipids
and incident BMLs is presented in Table 4. Fourteen
incident BMLs occurred across all four sites (medial
tibial, medial femoral, lateral tibial, and lateral femoral).
Total fat intake was protective against incident BMLs
after adjustment for age, sex, BMI, and ROA. Saturated
fat was also protective against incident BMLs in a multi-
variable model. In regard to serum lipids, HDL choles-
terol was protective against incident BMLs after
adjustment for age, sex, BMI, ROA, and statin use.
In a separate analysis that did not define incident
BMLs by 25 mm2 (that is, including all those who devel-
oped a BML of any size; n = 24), our results are largely
Table 1 Characteristics of participants according to








Age (year) 63.2 (7.3) 63.2 (7.2) 0.99
Female sex (%) 56 44 0.02
BMI (kg/m2) 27.1 (4.0) 28.3 (5.0) 0.01
Current smokers (%) 13 8 0.13
Cardiovascular disease (%) 4 9 0.07
Diabetes (%) 8 6 0.36
Statin use (%) 17 20 0.45
ROA present (%) 57 59 0.70
Dietary factors
Energy Intake (kJ/day) 7,512
(2,378)
7,800 (2,941) 0.30
Total fat (g/day) 71.5 (25.9) 74.2 (34.5) 0.40
Monounsaturated fat (g/
day)
24.9 (9.8) 25.7 (12.8) 0.50
Polyunsaturated fat (g/day) 11.8 (5.0) 11.6 (6.1) 0.67
Saturated fat (g/day) 28.6 (12.3) 30.4 (15.2) 0.19
Total carbohydrates (g/day) 205.1 (67.8) 214.3 (76.1) 0.21
Total protein (g/day) 84.7 (31.4) 87.2 (43.1) 0.52
Total sugar (g/day) 95.6 (36.3) 100.5 (42.0) 0.22
Lipids
Total cholesterol (mmol/L) 5.7 (1.1) 5.4 (1.1) 0.01
Triglycerides (mmol/L) 1.5 (0.9) 1.5 (0.8) 0.99
LDL cholesterol (mmol/L) 3.6 (0.9) 3.5 (1.0) 0.10
HDL cholesterol (mmol/L) 1.4 (0.4) 1.3 (0.3) 0.01
Values expressed as mean (standard deviation), except for percentages. P
values determined by t test or c2 test (where appropriate). Boldface denotes a
statistically significant result. BMI, body mass index; BMLs, bone marrow
lesions; HDL, high-density lipoprotein; LDL, low-density lipoprotein; ROA,
radiographic osteoarthritis.
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consistent but appeared weaker, suggesting that mea-
surement error increased when we did not define inci-
dent BMLs by 25 mm2.
Additional analysis
Additional data on cartilage defects and meniscal
pathology were available in this study. The dietary fac-
tors found to be associated with BML changes (energy,
carbohydrate, and sugar intake) were not associated
with cartilage defects, meniscal extrusion, or meniscal
tears cross-sectionally (all P > 0.05) or longitudinally (all
P > 0.05) in univariate and multivariable analysis, adjust-
ing for age, sex, BMI, baseline BMLs, smoking, cardio-
vascular diseases, diabetes, and ROA. HDL cholesterol
was also not associated with cartilage defects, meniscal
extrusion, or meniscal tears cross-sectionally (all P >
0.05) or longitudinally (all P > 0.05) in univariate and
multivariable analysis adjusting for age, sex, BMI,
Table 3 The association between dietary factors and lipids with a change in total BML size
Univariate Multivariablea
b (95% CI) P b (95% CI) P
Dietary factors
Energy intake 8.60 (-2.46, 19.67) 0.127 15.44 (1.71, 29.16) 0.028
Total fat 1.86 (-9.24, 12.95) 0.742 7.70 (-6.69, 22.09) 0.293
Carbohydrate 14.45 (3.45, 25.46) 0.010 19.27 (6.23, 32.31) 0.004
Protein 5.32 (-5.76, 16.41) 0.346 12.00 (-1.80, 25.79) 0.088
Sugars 14.53 (3.52, 25.53) 0.010 16.90 (4.38, 29.42) 0.008
Individual fats
Monounsaturated fat 3.37 (-7.73, 14.46) 0.551 10.00 (-4.50, 24.50) 0.176
Polyunsaturated fat 6.26 (-4.83, 17.34) 0.268 11.17 (-1.85, 24.20) 0.092
Saturated fat -1.88 (-12.97, 9.22) 0.740 1.37 (-12.49, 15.22) 0.846
Lipids
Total cholesterol -5.45 (-16.62, 5.72) 0.338 -6.02 (-18.85, 6.82) 0.357b
Triglycerides -7.24 (-18.42, 3.95) 0.204 -6.40 (-19.05, 6.25) 0.321b
LDL cholesterol 1.62 (-9.59, 12.83) 0.776 -0.97 (-14.27, 12.32) 0.885b
HDL cholesterol -11.18 (-22.30, -0.05) 0.049 -11.66 (-25.08, 1.76) 0.088b
Values are expressed as a change in total BML size (mm2) per 1 standard deviation increase in dietary or lipid factor. aAdjusted for age, sex, body mass index,
baseline BMLs, smoking, cardiovascular disease, diabetes, radiographic osteoarthritis, and time to follow-up. bFurther adjusted for statin use. Boldface denotes
statistically significant result. 95% CI, 95% confidence interval; b, beta coefficients; BML, bone marrow lesion; HDL, high-density lipoprotein; LDL, low-density
lipoprotein; P, P value.
Table 2 The association between baseline BMLs, dietary factors, and lipidsa
Univariate Multivariableb
OR (95% CI) P OR (95% CI) P
Dietary factors
Energy intake 1.12 (0.91, 1.36) 0.285 1.07 (0.84, 1.35) 0.592
Total fat 1.09 (0.89, 1.33) 0.385 1.06 (0.84, 1.34) 0.630
Carbohydrate 1.14 (0.93, 1.39) 0.206 1.08 (0.85, 1.36) 0.525
Protein 1.07 (0.88, 1.30) 0.517 1.03 (0.82, 1.29) 0.785
Sugars 1.13 (0.93, 1.39) 0.217 1.11 (0.89, 1.39) 0.344
Individual fats
Monounsaturated fat 1.07 (0.88, 1.31) 0.502 1.02 (0.81, 1.29) 0.849
Polyunsaturated fat 0.96 (0.78, 1.17) 0.672 0.92 (0.73, 1.15) 0.455
Saturated fat 1.14 (0.94, 1.40) 0.187 1.14 (0.90, 1.44) 0.283
Lipids
Total cholesterol 0.76 (0.61, 0.95) 0.015 0.81 (0.63, 1.02) 0.074c
Triglycerides 1.00 (0.82, 1.22) 0.996 0.90 (0.72, 1.13) 0.384c
LDL cholesterol 0.84 (0.68, 1.03) 0.101 0.88 (0.69, 1.11) 0.280c
HDL cholesterol 0.77 (0.62, 0.95) 0.016 0.89 (0.70, 1.14) 0.357c
aBML absent (226) versus present (168). Odds ratios (ORs) have been standardized. bAdjusted for age, sex, body mass index, smoking, cardiovascular diseases,
diabetes, and radiographic osteoarthritis. cFurther adjusted for statin use. Boldface denotes a statistically significant result. BMLs, bone marrow lesions; 95% CI,
95% confidence interval; HDL, high-density lipoprotein; LDL, low-density lipoprotein; P, P value.
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baseline BMLs, smoking, cardiovascular diseases, dia-
betes, ROA, and statin use.
Information also was available about physical activity.
When the BML models were further adjusted for base-
line steps/day, the results were largely unchanged.
Discussion
This longitudinal study reports associations between
dietary factors, serum lipids, and BMLs. Despite an
absence of cross-sectional associations, baseline energy,
carbohydrate, and sugar intake were associated with
increases in BML size. HDL cholesterol tended to be
associated with a decrease in BML size and was protec-
tive against incident BMLs and associated with BML
resolution. Total fat and saturated fat intake was protec-
tive against incident BMLs.
BMLs are associated with malalignment [3,9],
increased loading [39], and increased body weight
[40,41], emphasizing the relation between mechanical
loading and BMLs. However, recent studies have sug-
gested associations between BMLs and dietary fat intake
[16,17], suggesting a systemic role in BML pathology.
Although we did not find any associations between fat
intake and BML change, an exploratory analysis examin-
ing other dietary factors showed interesting findings.
Total energy, carbohydrate, and sugar intake were posi-
tively associated with BML change. This suggests that
an increase in these dietary factors may be detrimental
to BMLs. Carbohydrate and sugar intake could be surro-
gate measures for increasing energy, and it seems most
likely that increased energy is the major contributor to
BMLs. Evidence shows that a high-energy diet increases
free radical production and oxidative stress [42,43],
which could be having an effect on BMLs. Additionally,
the association we found was on a continuous scale;
therefore, decreased energy, carbohydrate, and sugar
intake was associated with BML decreases. Relating to
this, evidence also shows that caloric restriction has
antioxidative and antiinflammatory vasoprotective effects
in both animal and human studies [44,45]. Therefore, a
role may exist for dietary modification to alter BML nat-
ural history. However, the relation we report between
dietary factors and BMLs may not be causal, and it may
be that factors associated with diet are the underlying
cause (for example, physical activity). In this study, we
also collected information about physical-activity levels
in the form of steps/day measured by pedometers for 2
weeks per year. This is a good reflection of usual physi-
cal activity [46,47]. When we further adjusted for steps/
day in the analyses, the results were largely unchanged,
suggesting that the association is independent of physi-
cal activity. However, it is possible that other unknown
confounders exist. Overall, these findings are novel and
hypothesis generating, but must be confirmed in other
studies.
To compare with previous studies, we did a separate
analysis examining only incident BMLs. Total fat and
saturated fat intake was protective against incident
BMLs. These findings were unexpected and inconsistent.
We found no associations between fat and BMLs in the
cross-sectional analysis (Table 2) or in the longitudinal
analysis (Table 3), in which we used a continuous
Table 4 The association between baseline dietary factors and lipids with incident BMLsa
Univariate Multivariableb
OR (95% CI) P OR (95% CI) P
Dietary factors
Energy intake 0.68 (0.34, 1.37) 0.282 0.64 (0.29, 1.39) 0.257
Total fat 0.40 (0.17, 0.93) 0.034 0.32 (0.12, 0.86) 0.023
Carbohydrate 0.96 (0.53, 1.71) 0.877 0.95 (0.51, 1.75) 0.857
Protein 0.79 (0.38, 1.67) 0.542 0.78 (0.35, 1.75) 0.552
Sugars 0.98 (0.54, 1.75) 0.933 0.96 (0.52, 1.73) 0.856
Individual fats
Monounsaturated fat 0.49 (0.22, 1.09) 0.080 0.41 (0.16, 1.04) 0.061
Polyunsaturated fat 0.82 (0.44, 1.52) 0.523 0.82 (0.42, 1.57) 0.540
Saturated fat 0.29 (0.11, 0.78) 0.014 0.24 (0.08, 0.72) 0.010
Lipids
Total cholesterol 0.81 (0.44, 1.46) 0.479 0.67 (0.33, 1.35) 0.262c
Triglycerides 0.69 (0.33, 1.45) 0.329 0.75 (0.34, 1.65) 0.474c
LDL cholesterol 1.18 (0.67, 2.07) 0.570 1.05 (0.55, 1.98) 0.886c
HDL cholesterol 0.52 (0.27, 1.03) 0.060 0.34 (0.14, 0.78) 0.011c
aNo BML present at baseline and follow-up (n = 212) versus incident BML (n = 14) at any site (medial tibial, medial femoral, lateral tibial, and lateral femoral).
Odds ratios (ORs) have been standardized. bAdjusted for age, sex, body mass index, and radiographic osteoarthritis. cFurther adjusted for statin use. Boldface
denotes a statistically significant result. BML, bone marrow lesion; 95% CI, 95% confidence interval; HDL, high-density lipoprotein; LDL, low-density lipoprotein; P,
P value.
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measure of BML change. Traditionally, longitudinal stu-
dies are superior for demonstrating causal relations;
however, our results also conflict with a recent longitu-
dinal study by Wang et al. [17], which showed that
increased saturated fat is associated with incident BMLs.
These differences could reflect multiple comparisons in
our current study. Alternatively, the discrepancy may
reflect differences among study samples. In the study by
Wang et al. [17] participants included only those with-
out clinical signs of knee OA. Furthermore, the collec-
tion of dietary-intake data in the study by Wang et al.
[17] occurred 10 to 14 years before the study period,
rather than immediately before. It is possible that signif-
icant alterations in dietary behavior occurred within this
time frame; however, some evidence indicates that nutri-
ent intake is relatively stable and tends to be more
stable with increasing age [48,49]. Most important, we
only had 14 incident BMLs. However, with relatively
few incident cases, we still see significant findings. Inci-
dent BMLs are a rare outcome, and the previous study
by Wang et al. [17] also had a low number of incident
BMLs (n = 32). It does seem logical that fat intake
could be detrimental to BML development, given the
histology of BMLs and the recent evidence linking them
to vascular disease [29]. Therefore, our finding that fat
is protective is surprising, and further work should be
done to explore fat intake with BML development and
progression. Specifically, now given the discrepant find-
ings reported for fat intake and incident BMLs, we sug-
gest that this should be explored in different study
samples, with and without clinical knee OA. Interven-
tional trials are also an option, as they will better con-
trol for unmeasured confounders. This could be done in
both animal and human studies. To conclude, the cur-
rent available evidence indicates that fat plays a role in
BML development; however, the direction of the effect
is unclear, and larger studies must verify our finding
that fat is protective against incident BMLs.
This study has shown inconsistencies with dietary fac-
tors other than fat. Total energy and carbohydrate and
sugar intake were associated with BML change but
showed no association with incident BMLs. The analysis
with dietary components including energy, carbohydrate,
protein, and sugar intake was hypothesis generating and
suggests that the association between diet and BMLs is
different for incident BMLs versus progressing BMLs.
However, this must be verified in future studies.
A recent study by Davies-Tuck et al. [29] found that
serum cholesterol and triglycerides were associated
with an increased incidence of BMLs in asymptomatic
women. In the current study, we did not find any asso-
ciations between total cholesterol, triglycerides, and
BMLs; however, we did find that HDL cholesterol
tended to be associated with a decrease in BML size.
In separate analyses, we found that HDL cholesterol
was protective against incident BML development and
associated with BML resolution. This provides consis-
tent evidence that HDL cholesterol may have positive
effects on BML pathology. It has been previously pos-
tulated that atheromatous vascular disease may contri-
bute to the development of OA through its effects on
subchondral bone [18]. Subchondral bone ischemia
may be one mechanism by which vascular pathology
contributes to the development of BMLs [19]. HDL
cholesterol is considered to be protective against vas-
cular pathology through cholesterol transport, antiin-
flammatory, and antioxidant effects [50], and therefore
may help to reduce BML development and
progression.
In this study, we were able to examine the effect of
both increasing and decreasing BMLs, which other stu-
dies in the past have not been able to do [17,29]. The
results were independent of potential confounders, such
as smoking, cardiovascular diseases, diabetes, ROA,
steps/day, and statin use. However, some limitations to
this study exist. First, a 2-D assessment of BMLs was
made, by using the slice with the greatest BML size.
This may bias toward shallow but flat lesions. The
majority of previous studies also grade BMLs on the
slice with the greatest BML size; however, they use a
semiquantitative scale (0 to 3) rather than an areal mea-
sure. We acknowledge that our measure of BMLs is
only a surrogate measure of volume. Recent methods
have been developed to measure BML volume by using
a autoregression model [51,52]. It is our view that the
slice thickness (4 mm) and interslice gap (0.5 to 1.0
mm) of our imaging protocol were too large to estimate
volume with sufficient accuracy. Although our areal
measure may contain some measurement error, it has
been demonstrated to be more sensitive to change over
time, compared with a semiquantitative measure of
BMLs [53]. Second, we did not measure knee alignment,
which has been shown to be associated with BMLs [3,9].
Third, because of a small number of incident BMLs (n
= 14), we consider our finding that fat is protective
against incident BMLs preliminary and must be repro-
duced in a larger study. Last, baseline and follow-up
MRIs were read paired with the chronologic order
known to the observer. This was done to identify the
same lesion at follow-up. With few exceptions, the
reader was confident that the same BML was assessed at
follow-up. If a different BML were assessed at follow-up
(that is, because it was the largest at that site at follow-
up), this would increase our measurement error and
dilute the effects we are seeing. However, as stated ear-
lier, this was very rare, and in most cases, the reader
was able to assess the same BML at baseline and follow-
up.
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Conclusion
In conclusion, energy, carbohydrate, and sugar intake
may be risk factors for BML development and progres-
sion. Fat was protective against incident BMLs, which is
inconsistent with previous work and requires verification
in other studies. HDL cholesterol appears to have pro-
tective effects on BMLs. Overall, this study suggests that
macronutrients and serum lipids may be important in
BML etiology. Multiple mechanisms exist by which diet
and lipids could contribute to BML pathology, and
further investigation into the relation between diet,
lipids, and BMLs is warranted.
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